Mounjaro Weight Loss Calculator

Understanding Mounjaro (Tirzepatide) for Weight Loss

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly. Originally approved for type 2 diabetes, it has become the most effective weight loss medication ever studied in clinical trials. Its weight-loss specific version, Zepbound, was FDA-approved in November 2023 for chronic weight management.

Unlike semaglutide (Ozempic/Wegovy), which targets only GLP-1 receptors, tirzepatide activates both GIP and GLP-1 receptors. This dual mechanism produces greater appetite suppression, improved insulin sensitivity, and enhanced fat metabolism — leading to significantly more weight loss in clinical trials.

Mounjaro Dosing Schedule

Tirzepatide follows a gradual dose-escalation schedule to minimize gastrointestinal side effects. Each dose level is maintained for at least 4 weeks before increasing:

Mounjaro Results by Starting Weight

Your starting weight significantly affects the total pounds lost. Here are estimated results on the maximum 15mg dose over 12 months:

Mounjaro vs Ozempic: Key Differences

Frequently Asked Questions

How much weight will I lose on Mounjaro in 3 months?

Based on SURMOUNT-1 clinical data, most patients lose 8-15% of their starting body weight in the first 3 months on tirzepatide, depending on the dose achieved. For a 230 lb person, that's approximately 18-35 lbs. Results accelerate as you titrate to higher doses.

What is the average weight loss on Mounjaro 15mg?

In the SURMOUNT-1 trial, patients on tirzepatide 15mg (the highest dose) lost an average of 20.9% of their body weight over 72 weeks. For someone starting at 230 lbs, that's approximately 48 lbs. Nearly half (48%) of patients on 15mg lost more than 20% of their body weight.

How accurate is this Mounjaro calculator?

Our calculator uses dose-specific weight loss rates from the SURMOUNT-1 clinical trial. These represent population averages — individual results vary based on starting weight, adherence, diet, exercise, and biological factors. The calculator provides a reasonable estimate for planning purposes, not a medical guarantee.

Is Mounjaro better than Ozempic for weight loss?

Clinical data suggests Mounjaro (tirzepatide) produces greater weight loss than Ozempic (semaglutide). SURMOUNT-1 showed 20.9% loss on tirzepatide 15mg vs 14.9% on semaglutide 2.4mg in STEP-1. Tirzepatide is a dual GIP/GLP-1 agonist targeting two hormonal pathways.

How long does it take to see results on Mounjaro?

Most patients notice appetite changes within the first week and visible weight loss by weeks 4-6. Significant body changes appear by months 3-4 as you reach therapeutic doses. Maximum weight loss typically occurs between months 12-18 on the highest tolerated dose.

Can I visualize my Mounjaro weight loss results?

Yes. After using this calculator, you can upload a photo to BeforeAfterFit to see an AI-generated preview of your body at your projected weight. Select GLP-1 Journey mode with Mounjaro and your target timeline to see realistic visualization in under 30 seconds.

What is the difference between Mounjaro and Zepbound?

Mounjaro and Zepbound are both tirzepatide made by Eli Lilly. Mounjaro is FDA-approved for type 2 diabetes, while Zepbound is FDA-approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition. The active ingredient, doses, and injection device are identical — the difference is the approved indication and insurance coverage.

What dose of Mounjaro causes the most weight loss?

The highest approved dose of tirzepatide, 15mg, produces the most weight loss. In the SURMOUNT-1 trial, 15mg resulted in 20.9% average body weight loss over 72 weeks, compared to 19.5% on 10mg and 15.0% on 5mg. However, not all patients tolerate the highest dose — your doctor will titrate based on your response and side effects.